Product logins

Find logins to all Clarivate products below.


ENT Devices – Market Insights – Asia Pacific (Supplemental)

Driven by the increasing prevalence of ear, nose, and throat disease and patient awareness of ENT procedures in this region, the Asia Pacific ENT device market will continue to expand through 2033, despite the competition from nonsurgical alternative treatments, such as antibiotics. Moreover, there will be increasing adoption of innovative and premium-priced products, such as flexiblescopes, RF handpieces, and powered instruments; as a result, the Asia Pacific market for ENT devices will grow at a modest pace.

This Medtech 360 Report provides high-level market metrics for ENT devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the region from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Pain Management Devices – Market Insights – United States
The US pain management device market is driven by continuous product innovation aimed at enhancing treatment efficacy and addressing new indications. Favorable clinical evidence and pain management…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…